Patent details

Basic Information

Publication number:

EP3533792

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP191692755

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

CRYSTALLINE FORMS OF AN ANDROGEN RECEPTOR MODULATOR

French Title of Invention:

FORMES CRISTALLINES D'UN MODULATEUR DE RÉCEPTEUR D'ANDROGÈNE

German Title of Invention:

KRISTALLINE FORMEN EINES ANDROGENREZEPTORMODULATORS

SPC Number:

LUC00236

Dates

Filing date:

04/06/2013

Grant date:

05/05/2021

EP Publication Date:

04/09/2019

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

05/05/2021

EP B1 Publication Date:

05/05/2021

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

04/06/2033

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

02/09/2022

 

 

Name:

Aragon Pharmaceuticals, Inc.

Address:

10990 Wilshire Blvd. Suite 440, CA90024, Los Angeles, California, United States (US)

From:

28/04/2021

 

 

Name:

Sloan Kettering Institute For Cancer Research

Address:

1275 York Avenue, New York, NY 10065, United States (US)

History of Owners

From:

28/04/2021

To:

02/09/2022

Name:

Aragon Pharmaceuticals, Inc.

Address:

10990 Wilshire Blvd. Suite 300, Los Angeles, CA 90024, United States (US)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

10/05/2021

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

SMITH, Nicholas D.

Address:

United States (US)

2

Name:

DILHAS, Anna

Address:

Switzerland (CH)

3

Name:

OUERFELLI, Ouathek

Address:

United States (US)

4

Name:

HERBERT, Mark R.

Address:

United States (US)

Priority

Priority Number:

201261656888 P

Priority Date:

07/06/2012

Priority Country:

United States (US)

Classification

IPC classification:

C07D 401/04; A61K 31/4439; A61K 31/4184; A61P 35/00;

Publication

Bulletin

1

Bulletin Heading:

CO

Bulletin edition number:

2022/11

Publication date:

04/10/2022

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

2

Bulletin Heading:

VB2

Bulletin edition number:

2025/03

Publication date:

06/02/2025

Description:

Section J : Applications for patents or supplementary protection certificates having been restored (art. 40 of the law) Patents or supplementary protection certificates having been restored (art. 70 of the law)

European Patent Bulletin

1

Issue number:

202118

Publication date:

05/05/2021

Description:

Grant (B1)

2

Issue number:

202436

Publication date:

04/09/2024

Description:

Opposition rejected; Patent maintained as granted

3

Issue number:

202123

Publication date:

09/06/2021

Description:

Application number/publication number of the divisional application (Art. 76) changed

Deed

Change of owner(s)

Change Kind/ Decision Type:

Change of owner(s) name/address

Deed Number:

RC20220000350A

Date Registered:

02/09/2022

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

OFFICE FREYLINGER S.A.

Journal Edition Number:

Text:

change of owners address

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

1

Name:

Sloan Kettering Institute For Cancer Research

Address:

1275 York Avenue, New York, NY 10065, United States (US)

2

Name:

Aragon Pharmaceuticals, Inc.

Address:

10990 Wilshire Blvd. Suite 440, CA90024, Los Angeles, United States (US)

Removed Pledgee

Name:

Address:

Annual Fees

Annual Fee Due Date:

30/06/2026

Annual Fee Number:

14

Annual Fee Amount:

198 Euro

Expected Payer:

Last Annual Fee Payment Date:

30/05/2025

Last Annual Fee Paid Number:

13

Last Annual Fee Paid Amount:

180 Euro

Payer:

CPA GLOBAL THE IP PLATFORM

Filing date	Document type	Number of pages
10/05/2021	Outgoing Correspondence	1
10/05/2021	Power Of Attorney	1
02/09/2022	Request For Change	1
02/09/2022	Outgoing Correspondence	1